Sun Pharmaceutical Industries is currently trading at Rs. 643.55, up by 4.05 points or 0.63% from its previous closing of Rs. 639.50 on the BSE.
The scrip opened at Rs. 644.80 and has touched a high and low of Rs. 649.40 and Rs. 641.00 respectively. So far 210263 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 434.80 on 22-May-2018.
Last one week high and low of the scrip stood at Rs. 678.80 and Rs. 636.00 respectively. The current market cap of the company is Rs. 154948.39 crore.
The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.98% and 12.64% respectively.
Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has agreed to acquire shares of Tarsius Pharma (Tarsius), Israel, by way of subscription of 345,622 ordinary shares of nominal value of NIS 0.01 each, representing 18.75% of shares of Tarsius, on a fully diluted basis.
Tarsius is an Israel based early stage Research and Development (R&D) company focusing on development of drug candidates in the field of Ophthalmology. The cost of acquisition is $3 million and indicative time period for completion of the acquisition is before September 15, 2018.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |